piperacillin and tazobactam
Generic: piperacillin and tazobactam
Labeler: apotex corp.Drug Facts
Product Profile
Brand Name
piperacillin and tazobactam
Generic Name
piperacillin and tazobactam
Labeler
apotex corp.
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Routes
Active Ingredients
piperacillin sodium 3 g/15mL, tazobactam sodium .375 g/15mL
Manufacturer
Identifiers & Regulatory
Product NDC
60505-6157
Product ID
60505-6157_0702bfe3-61ba-4c3e-a9e4-ceafca2a8821
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA204959
Listing Expiration
2026-12-31
Marketing Start
2019-03-15
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
605056157
Hyphenated Format
60505-6157
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
piperacillin and tazobactam (source: ndc)
Generic Name
piperacillin and tazobactam (source: ndc)
Application Number
ANDA204959 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 3 g/15mL
- .375 g/15mL
Packaging
- 10 VIAL, SINGLE-DOSE in 1 CARTON (60505-6157-4) / 15 mL in 1 VIAL, SINGLE-DOSE (60505-6157-0)
Packages (1)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "0702bfe3-61ba-4c3e-a9e4-ceafca2a8821", "openfda": {"upc": ["0360505615902", "0360505615742", "0360505615643", "0360505615605", "0360505615704", "0360505615940"], "unii": ["UXA545ABTT", "M98T69Q7HP"], "rxcui": ["1659131", "1659137", "1659149"], "spl_set_id": ["2c8f06a2-49b2-4169-94ef-182d13d248bf"], "manufacturer_name": ["Apotex Corp."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, SINGLE-DOSE in 1 CARTON (60505-6157-4) / 15 mL in 1 VIAL, SINGLE-DOSE (60505-6157-0)", "package_ndc": "60505-6157-4", "marketing_start_date": "20190315"}], "brand_name": "Piperacillin and Tazobactam", "product_id": "60505-6157_0702bfe3-61ba-4c3e-a9e4-ceafca2a8821", "dosage_form": "INJECTION, POWDER, FOR SOLUTION", "pharm_class": ["Penicillin-class Antibacterial [EPC]", "Penicillins [CS]", "beta Lactamase Inhibitor [EPC]", "beta Lactamase Inhibitors [MoA]"], "product_ndc": "60505-6157", "generic_name": "PIPERACILLIN and TAZOBACTAM", "labeler_name": "Apotex Corp.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Piperacillin and Tazobactam", "active_ingredients": [{"name": "PIPERACILLIN SODIUM", "strength": "3 g/15mL"}, {"name": "TAZOBACTAM SODIUM", "strength": ".375 g/15mL"}], "application_number": "ANDA204959", "marketing_category": "ANDA", "marketing_start_date": "20190315", "listing_expiration_date": "20261231"}